Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 8, 2009, Pages 569-576

  Upadhye, Vijay ^a   Majumdar, Anindita ^a   Gomashe, Ashok ^c   Joshi, Deepti ^b   Gangane, Nitin ^b   Thamke, Dipak ^b   Mendiratta, Deepak ^b   Harinath, B C ^a  

^a MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^b Mahatma Gandhi Institute of Medical Sciences   (Spain)

^c Shivaji College of Science   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 3,4 DICHLOROISOCOUMARIN; 4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; BACTERIUM ANTIBODY; BENZYLSULFONYL FLUORIDE; EDETIC ACID; ISONIAZID; METALLOPROTEINASE INHIBITOR; SERINE PROTEASE ANTIBODY; SERINE PROTEINASE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CELLS, CULTURED; COLONY COUNT, MICROBIAL; ENZYME INHIBITORS; HUMANS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; SERINE PROTEASES;

EID: 70849103042     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540903015109     Document Type: Article

References (25)

1. Chaparas SD. Immunity in tuberculosis. Bull W H O 1982;/ 4:/447-62.
2. Deirdre MK, Annemieke MB, Seonadh MO, Mary PO, Joseph K. Bystander mcrophage apoptosis after Mycobacterium tuberculosis H37Ra infection. Infect Immun 2008; 76:351-360
3. Maeda H. Role of microbial proteases in pathogenesis. Microbiol Immunol 1996;/40:/685-99.
4. Nair ER, Banerjee S, Gupta S, Kumar S, Reddy MVR, Harinath BC. Seroreactivity and characterization of 31 kDa M.tb. secretory protease of diagnostic interest in tuberculosis. Trends Clin Biochem Lab Med 2003;330-338
5. Shende N, Gupta S, Bhatia AS, Kumar S, Harinath BC. Detection of free and immune-complexed serine protease and its antibody in TB patients with and without HIV coinfection. Int J Tuberc Lung Dis 2005;/9:/915-9.
6. Miyagawa S, Nishino N, Kamata R, Okamura R, Maeda H. Effects of protease inhibitors on growth of Serratia marcescens and Pseudomonas aeruginosa. Microb Pathog 1991;/11:/ 137-141
7. Travis J, Potempa J, Maeda H. Are bacterial proteinases pathogenic factors? Trends Microbiol 1995;/3:/405-7.
8. Pramanik J, Lodam AN, Reddy MVR, Narang P, Harinath BC. Increased yield of excretory secretory antigen with thyroxine supplement in in vitro culture of tubercle bacilli. Ind J Tub 1997;/44:/185-90.
9. Nair ER, Banerjee S, Kumar S, Reddy MVR, Harinath BC. Purification and characterization of a 31 kDa mycobacterial excretory-secretory antigenic protein with a diagnostic potential in pulmonary tuberculosis. Ind J Chest Dis Allied Sci 2001;/43:/81-90.
10. Harinath BC, Kumar S, Saha-Roy S, Hirudkar S, Upadhye V, Shende N. A cocktail of affinity-purified antibodies reactive with diagnostically useful mycobacterial antigens ES-31, ES-43 and EST-6 for detecting the presence ofMycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006;/55:/65-9.
11. Nair ER, Banerjee S, Kumar S, Reddy MVR, Harinath BC. Isolation of Mycobacterium tuberculosis 31 kDa antigen protein of diagnostic interest from culture filtrate using anti- ES-31 antibody by affinity chromatography. Indian J Clin Biochem 2001;/16:/132-5.
12. Upadhye V, Gomashe A, Kumar S, Harinath BC. Isolation, characterization and kinetic studies on SEVA TB ES-31 antigen, a metalloserine protease of interest in diagnosis. Indian J Tuberc 2009;56:22-29
13. Palomino JC, Leão SC, Ritacco V. Tuberculosis 2007: From Basic Science to Patient Care, 1st edn. Chapter drug resistance and drug resistance detection, pp. 642.
14. Beggs W, Jenne J. Growth inhibition of Mycobacterium tuberculosis after single-pulsed exposures to streptomycin, ethambutol and rifampicin. Infect Immun 1970;/2:/479-83.
15. Majumdar A, Upadhye V, Harinath BC. Peroxidase enzyme immunoassay for circulating SEVA TB ES-31 antigen in pulmonary tuberculosis sera. Biomedical Research 2008;/19:/ 201-206
16. Zhang M, Gong J, Lin Y, Barnes P. Growth of virulent and avirulent Mycobacterium tuberculosis strain in human macrophages. Infect Immun 1998;/66:/794-9.
17. Belisle JT, Vissa VD, Sievert K, Takayama K, Brennan P, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997;/276:/ 1420-1422
18. Laal S, Samanich KM, Sonnenberg MG, Zolla-Pazner S, Phadtare JM, Belisle JT. Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol 1997;/4:/49-56.
19. Nair ER, Banerjee S, Kumar S, Harinath BC. Isolation and characterization of a 31 kDa mycobacterial antigen from tuberculous sera and its identification with in vitro released culture filtrate antigen of M. tb. H37Ra bacilli. Scand J Infect Dis 2000;/32:/551-6.
20. Brown GD, Dave JA, Gey van Pittius NC, Stevens L, Ehlers MRW, Beyers AD. The mycosins of Mycobacterium tuberculosis H37Rv: a family of subtilisin-like serine proteases. Gene 2000;/254:/147-55.
21. Dave JA, Pittius NCG, Beyers AD, Ehlers MRW, Brown GD. Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages. BMC Microbiol 2002;/2:/ 1-8.
22. Harth G, Horwitz MA. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 1999;/189:/1425-35.
23. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991;/59:/1905-10.
24. Lind A, Norlin M, Ouchterlony O. Studies on the precipitinogenic pattern of mycobacteria cultivated at various temperatures. Pneumologie 1970;/142:/283-9.
25. Marrakchi H, Laneelle G, Quemard A. InhA, a target of the anti-tuberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 2000;/ 146:/289-96.